Latest News about JNJ
Recent news which mentions JNJ
   7 Dividend Stocks to Buy and Never Sell: January 2024 Edition
   
  
  
  January 25, 2024
  From InvestorPlace
 
   The Analyst Verdict: Johnson & Johnson In The Eyes Of 12 Experts
   
  January 24, 2024
  Tickers 
   JNJ
  
  
  From Benzinga
 
   Gilead's Tecartus Dropped From FDA List Of CAR-T Therapy With Updated Label Warning Of "Risks Of Secondary Cancer'
   
  
  
  January 24, 2024
  From Benzinga
 
   What's Going On Johnson & Johnson Stock Today?
   
  
  
  January 24, 2024
  From Benzinga
 
   Nasdaq, S&P 500 Futures Jump As Wall Street Eagerly Awaits Tesla's Q4 Earnings: Analyst Says Rally Broadening But Favors These Stocks
   
  
  
  January 24, 2024
  From Benzinga
 
   Investor Optimism Improves Following Earnings Reports; S&P 500 Reaches Another High
   
  
  
  January 24, 2024
  From Benzinga
 
   Johnson & Johnson (JNJ) Q4 2023 Earnings Call Transcript
   
  January 23, 2024
  Tickers 
   JNJ
  
  
  From Motley Fool
 
   US Stocks Pause As Treasury Yields, Dollar Surge On Trimmed Fed Rate Cut Bets: What's Driving Markets Tuesday?
   
  
  
  January 23, 2024
  From Benzinga
 
   Johnson & Johnson's Settlement For Talc Cancer Lawsuits Reaches $700M Settlement With US States
   
  
  
  January 23, 2024
  From Benzinga
 
   What's Going On With Danish Healthcare Firm Genmab Stock?
   
  
  
  January 23, 2024
  From Benzinga
 
   10 Health Care Stocks With Whale Alerts In Today's Session
   
  
  
  January 23, 2024
  From Benzinga
 
   US Stocks Mixed; Johnson & Johnson Posts Upbeat Earnings
   
  
  
  January 23, 2024
  From Benzinga
 
   Johnson & Johnson's Clock 12% Q4 Revenue Growth, Cancer and Crohn's Disease Drugs Account as Largest Sellers
   
  
  
  January 23, 2024
  From Benzinga
 From Benzinga
 
   US Stocks Prepare For Nervy Start Ahead of Netflix, TI Earnings: Analyst Says Cash Waiting On Sidelines Could Flood Street If This Happens
   
  
  
  January 23, 2024
  From Benzinga
 
   2 Genius Safe Stocks to Buy for 2024 and Beyond
   
  
  
  January 23, 2024
  From Motley Fool
 
   Earnings Scheduled For January 23, 2024
   
  
  
  January 23, 2024
  From Benzinga
 
   Fear & Greed Index Remains In 'Greed' Zone; Dow Settles Above 38,000
   
  
  
  January 23, 2024
  From Benzinga
 
   Verizon, Netflix And 3 Stocks To Watch Heading Into Tuesday
   
  
  
  January 23, 2024
  From Benzinga
 
   S&P 500, Nasdaq, Dow Jones Strike All-Time Highs Ahead Of Key Earnings This Week: What's Driving Markets Monday?
   
  
  
  January 22, 2024
  From Benzinga
 
   10 Health Care Stocks Whale Activity In Today's Session
   
  
  
  January 22, 2024
  From Benzinga
 
   Johnson & Johnson Secures Complete FDA Approval For Bladder Cancer Drug Balversa, After Almost Five Years Of Accelerated Approval
   
  
  
  January 22, 2024
  From Benzinga
 
   Johnson & Johnson's Q4 Earnings: Spotlight On Dividend Security Following Kenvue Split, Legal Costs, Acquisitions
   
  
  
  January 22, 2024
  From Benzinga
 
   Tesla, Netflix, Intel Take Center Stage In Pivotal Q4 Earnings Week As S&P 500 Eyes Breaking New Highs
   
  
  
  January 22, 2024
  From Benzinga
 
   I'm Putting My Cash Stockpile to Work on These 3 Stocks
   
  
  
  January 21, 2024
  From Motley Fool
 
   Nearing Retirement? These Stocks Are as Safe as They Come
   
  
  
  January 21, 2024
  From Motley Fool
 From Motley Fool
 
   My 5 Top Dividend Stocks to Buy Hand Over Fist in 2024
   
  
  
  January 21, 2024
  From Motley Fool
 
   3 High-Flying Stocks That Could Soar Even More in 2024
   
  
  
  January 20, 2024
  From Motley Fool
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.